Although these cell lines were of the same genetic background, primary tumor-derived cells expressed low levels of the chemokine receptor CCR4, whereas brain-metastasizing melanoma cells expressed significantly higher levels of CCR4. The gene discussed is CCR4; the disease is neoplasm.